Skip to main navigation

preloader

Overview
News & Events
- News Releases
- Events
Presentations
SEC Filings
Stock Info
- Analyst Coverage
Corporate Governance
Resources & Contact

News Releases

Year

Cullinan Oncology to Present at the Barclays Global Healthcare Conference

March 9, 2022

Cullinan Oncology to Present Data Demonstrating Breadth and Progress of Its Immuno-Oncology Portfolio at AACR 2022

March 8, 2022

Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors

February 28, 2022

Cullinan Oncology to Present at SVB Leerink’s 11th Annual Global Healthcare Conference

February 7, 2022

Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment

January 10, 2022

Cullinan Oncology to Present at Upcoming Virtual Investor Conferences

January 5, 2022

FDA Grants Breakthrough Therapy Designation for Cullinan Oncology’s CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

January 4, 2022

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 17 of 17

Investor Tools

News & Events
- News Releases
- Events

Stock Info
- Stock Quote & Chart

Corporate Governance

Financials & Filings

IR Resources

Copyright © 2022 Cullinan Oncology, Inc.. All rights reserved

Site - Footer

Terms of Use/Privacy